Literature DB >> 3869650

Reaction of human sera from juvenile periodontitis, rapidly progressive periodontitis, and adult periodontitis patients with selected periodontopathogens.

J W Vincent, J B Suzuki, W A Falkler, W C Cornett.   

Abstract

The levels of serum antibody reactive to selected periodontopathogens were determined in 182 clinically characterized patients: 35 healthy control, 50 juvenile periodontitis, 42 adult periodontitis and 55 rapidly progressive periodontitis. Reactive antibody levels were determined using an enzyme-linked immunosorbent assay with whole cell preparations of Bacteroides gingivalis, Capnocytophaga (Bacteroides) ochraceus, Fusobacterium nucleatum and Actinobacillus actinomycetemcomitans (Y-4) serving as antigens. Increased reactivity to B. gingivalis and F. nucleatum was observed in all three disease groups studied while antibody reactive to A. actinomycetemcomitans was increased in juvenile and rapidly progressive periodontitis. Antibody levels reactive to C. ochraceus in healthy subjects did not differ from those observed in any disease patient groups. Possible implications in the etiology and progression of the diseases coupled with environmental changes which occur in the econiche of the periodontal pocket are described.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3869650     DOI: 10.1902/jop.1985.56.8.464

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  17 in total

1.  Immunoglobulin allotypes and immunoglobulin G subclass responses to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in early-onset periodontitis.

Authors:  J I Choi; M H Ha; J H Kim; S J Kim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Reevaluation of the chromosome 4q candidate region for early onset periodontitis.

Authors:  T C Hart; M L Marazita; K M McCanna; H A Schenkein; S R Diehl
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

3.  The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype-specific high-molecular-mass carbohydrate moiety of lipopolysaccharide.

Authors:  R C Page; T J Sims; L D Engel; B J Moncla; B Bainbridge; J Stray; R P Darveau
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

4.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  The relationship between colonization and haemagglutination inhibiting and B cell epitopes of Porphyromonas gingivalis.

Authors:  C G Kelly; V Booth; H Kendal; J M Slaney; M A Curtis; T Lehner
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

6.  Cell surface protein antigen from Wolinella recta ATCC 33238T.

Authors:  S Kokeguchi; K Kato; H Kurihara; Y Murayama
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

7.  Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high-responder patients.

Authors:  J V Califano; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

8.  Effect of treatment on titer, function, and antigen recognition of serum antibodies to Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis.

Authors:  K Sjöström; J Ou; C Whitney; B Johnson; R Darveau; D Engel; R C Page
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution.

Authors:  C Whitney; J Ant; B Moncla; B Johnson; R C Page; D Engel
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

10.  Bacteroides gingivalis-specific serum IgG and IgA subclass antibodies in periodontal diseases.

Authors:  T Ogawa; Y Kusumoto; S Hamada; J R McGhee; H Kiyono
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.